PMC: PMC11226645
Utilize specified medicines
Omega-3s can inhibit platelet aggregation, thrombin, and clot formation, as well as improve vasodilation
Annual List Review Process Every year, WADA leads the revision process concerning the List, beginning with an initial meeting in January and concluding with the publication of the List by 1 October
Drug-Disease Interactions TENXIMA 3D GLOW TABLET 10 may interact with diseases, including: History of thromboembolic disorders: Patients with a history of blood clots, stroke, or thrombosis should use this medicine cautiously, as tranexamic acid may increase the risk of clot formation
The bottom line: if a peptide's primary mechanism involves monoamine signalling, cardiovascular stimulation, or CNS activation, do not stack it with tesofensine without continuous cardiovascular monitoring